Skip to main content
HOLISTA COLLTECH LIMITED logo

HOLISTA COLLTECH LIMITED — Investor Relations & Filings

Ticker · HCT ISIN · AU000000HCT4 ASX Manufacturing
Open in API
Filings indexed 811 across all filing types
Latest filing 2025-04-16 Share Issue/Capital Cha…
Country AU Australia
Listing ASX HCT

About HOLISTA COLLTECH LIMITED

https://www.holistaco.com

Holista CollTech Limited is a research-driven company focused on the development and commercialization of natural health products and ingredients. The company specializes in three primary areas: ovine collagen, food-grade ingredients, and infection control solutions. Its proprietary collagen extraction technology produces high-quality, disease-free ovine collagen for the cosmetic and medical industries. In the food sector, the company develops low-glycemic index (GI) formulations for staple foods like bread, noodles, and pasta to address global health concerns such as diabetes and obesity. Additionally, Holista CollTech offers natural sanitization products based on plant-derived active ingredients. The company aims to provide scientifically validated solutions that enhance wellness and food quality through sustainable and natural processes.

Recent filings

Filing Released Lang Actions
Notification regarding unquoted securities - HCT 7 pages 22.5KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities' and details the issuance of unquoted securities by Holista Colltech Limited. It includes specifics about the securities issued, dates, and references to previous announcements (Appendix 3B). The content is focused on notifying the market about the issuance and conversion of securities, which aligns with announcements related to share issues or capital changes. There is no financial statement, management discussion, or audit information present. The document length is 7298 characters, which is sufficient for a detailed announcement but does not constitute a full financial report. Therefore, this document fits the category of Share Issue/Capital Change announcements.
2025-04-16 English
Resignation of Non-Executive Directors 1 page 105.1
Board/Management Information Classification · 100% confidence The document is an ASX release dated 16 April 2025 announcing the resignation of two non-executive directors from the company's board. It discusses changes in the board composition and the intention to appoint replacements. There is no financial data, no mention of a report or meeting results, and the content is focused solely on management changes. Therefore, this fits the category of Board/Management Information (MANG). The document length is short and it is a direct announcement, not a report or presentation.
2025-04-15 English
Supreme Court Proceedings against ProImmune 1 page
Legal Proceedings Report Classification · 95% confidence The document is an ASX release dated 1 April 2025 regarding Supreme Court proceedings against ProImmune. It references litigation details and the impact on the company's annual accounts for the year ending 31 December 2024, which will be lodged today. The document is short (2358 characters) and primarily announces legal proceedings and the delay in filing annual accounts. It does not contain the annual report itself or detailed financial data, but rather an announcement related to legal matters and report filing timing. Therefore, it fits best under Legal Proceedings Report (LTR) as it updates on significant lawsuits involving the company.
2025-03-31 English
Annual Report to shareholders 90 pages 3.1MB
Annual Report Classification · 100% confidence The document is titled 'Annual Report' and covers the financial year ended 31 December 2024. It includes detailed sections such as the Directors' report, Auditor's independence declaration, consolidated financial statements (profit or loss, financial position, changes in equity, cash flows), notes to the financial statements, directors' declaration, and independent auditor's report. The content includes comprehensive financial data, management commentary, corporate governance statement, and shareholder information. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. The presence of audited financial statements and detailed financial analysis confirms this is the official yearly report covering company activity and full financial performance, consistent with the definition of an Annual Report (10-K).
2025-03-31 English
Appendix 4G 13 pages 395.5KB
Regulatory Filings Classification · 95% confidence The document is titled 'Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations' and references ASX Listing Rules 4.7.3 and 4.10.3. It is a governance-related disclosure that accompanies the annual report, confirming compliance with corporate governance recommendations and providing a key to where governance disclosures can be found. The document is not the annual report itself but a regulatory appendix related to governance disclosures. It does not contain financial statements or detailed financial performance data. It is a regulatory filing required by the ASX to be lodged alongside the annual report but is distinct from the annual report. Therefore, the document fits best under Regulatory Filings (RNS) as it is a compliance document related to governance disclosures and listing rules, not a full report or presentation.
2025-03-31 English
Reinstatement to Quotation 1 page 111.8KB
Regulatory Filings Classification · 95% confidence The document is a market announcement from ASX Compliance dated 1 April 2025, stating that the suspension of trading in Holista Colltech Limited's securities will be lifted following the lodgement of its Annual Report and Appendix 4G for the financial year ended 31 December 2024. The document itself does not contain the Annual Report but announces the reinstatement to quotation contingent on the report's lodgement. The document length is short (661 characters) and serves as an announcement rather than the report itself. According to the MENU VS MEAL RULE, this is a Report Publication Announcement (RPA) or Regulatory Filing (RNS). Since it is a market announcement about reinstatement and report lodgement, it fits best under Regulatory Filings (RNS) as a general regulatory announcement rather than a direct report publication notice.
2025-03-31 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.